Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Understanding the Regulatory Landscape: A Comparison

To put BPC-157's status in perspective, it helps to compare it to other substances with different regulatory classifications. The lines can get blurry, so a clear table often helps our clients understand the landscape. Dietary Supplement Creatine Monohydrate N

This comparison does not assign a generated winner or score.

  • To put BPC-157's status in perspective, it helps to compare it to other substances with different regulatory classifications. The lines can get blurry, so a clear table often helps our clients understand the landscape.
  • Dietary Supplement
  • Creatine Monohydrate
  • No
  • Generally Recognized as Safe (GRAS)
  • Widely available and studied; legal to market for human consumption with appropriate claims.
  • Prescription Drug
  • Tesamorelin
  • Yes (under S2: Peptide Hormones, Growth Factors)
  • FDA-approved for a specific medical condition
  • Requires a prescription for human use; research is highly regulated. Explore research-grade Tesamorelin Peptide here.
  • Non-Approved Research Peptide
  • BPC-157
  • Yes (under S0: Non-Approved Substances)
  • Investigational New Drug (Not Approved)
  • Cannot be marketed for human use. Legal for laboratory research only. Purity and sourcing are paramount.
  • Anabolic Steroid
  • Testosterone (misuse)
  • Yes (under S1: Anabolic Agents)
  • Controlled Substance (Schedule III)
  • Highly illegal without a prescription; strictly banned in sports and heavily regulated for research.
  • This table makes the distinction incredibly clear. BPC-157 doesn't fit neatly into the box of a 'supplement' or a 'drug.' It inhabits a unique space: a molecule of high scientific interest that has not yet completed the long, arduous, and astronomically expensive journey to full regulatory approval. And until it does (if it ever does), it will remain on WADA's Prohibited List and off the pharmacy shelves.
More references

Related material